GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » Total Assets

Hofseth BioCare ASA (OSTO:HBCO) Total Assets : kr390.7 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA Total Assets?

Hofseth BioCare ASA's Total Assets for the quarter that ended in Mar. 2024 was kr390.7 Mil.

Warning Sign:

If a company builds assets at 22.2% a year, faster than its revenue growth rate of 15.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 3 years, the average Total Assets Growth Rate was 8.60% per year. During the past 5 years, the average Total Assets Growth Rate was 22.20% per year. During the past 10 years, the average Total Assets Growth Rate was 8.90% per year.

During the past 13 years, Hofseth BioCare ASA's highest 3-Year average Total Assets Growth Rate was 37.90%. The lowest was -13.00%. And the median was 11.50%.

Total Assets is connected with ROA %. Hofseth BioCare ASA's annualized ROA % for the quarter that ended in Mar. 2024 was -29.72%. Total Assets is also linked to Revenue through Asset Turnover. Hofseth BioCare ASA's Asset Turnover for the quarter that ended in Mar. 2024 was 0.13.


Hofseth BioCare ASA Total Assets Historical Data

The historical data trend for Hofseth BioCare ASA's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA Total Assets Chart

Hofseth BioCare ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 293.01 459.13 415.97 411.03 390.12

Hofseth BioCare ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.27 410.96 401.98 390.12 390.71

Hofseth BioCare ASA Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hofseth BioCare ASA's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=41.14+348.979
=390.1

Hofseth BioCare ASA's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=155.667+235.047
=390.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hofseth BioCare ASA  (OSTO:HBCO) Total Assets Explanation

Total Assets is connected with ROA %.

Hofseth BioCare ASA's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-116.028/( (390.119+390.714)/ 2 )
=-116.028/390.4165
=-29.72 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hofseth BioCare ASA's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=52.358/( (390.119+390.714)/ 2 )
=52.358/390.4165
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hofseth BioCare ASA Total Assets Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hofseth BioCare ASA (OSTO:HBCO) Business Description

Traded in Other Exchanges
Address
Kipervikgata 13, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Hofseth BioCare ASA (OSTO:HBCO) Headlines

No Headlines